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r Cliff K. Choong (Cambridge, United Kingdom). Among the
atients who underwent the RF ablation, did you and your co-
nvestigators do any intraoperative assessment to confirm trans-
urality of the ablation lines at all? Second, why do you think
here is a difference in these results between the two groups? Last,
n the basis of your findings, how has that influenced the practice
t the Mayo Clinic?
Dr Stulak. Intraoperatively, it seemed in this patient popula-
ion that RF was used mostly in patients who had numerous
oncomitant procedures. Because it is very time-consuming, we do
ot measure conduction block intraoperatively. It is hard to know
hy we saw the striking differences between the two procedures
hat we did. It is hard to know whether it is purely due to a
otential lack of transmurality. There are numerous factors that
ay contribute, including differences in the atrial characteristics in
erms of thickness, fibrotic scar in older patients, the amount of fat
round the pulmonary veins, as well as intraoperative factors such
s normothermia versus hypothermia, beating heart, endocardial
ersus epicardial. We think that it is impossible to apply uniform
nergy in a uniform fashion to atria that have very different
haracteristics. In our practice, although we believe that RF can be
sed as part of a concomitant procedure, if the indication for
peration is purely AF, CS offers the patient the best relief of AF.
Dr Niv Ad. (Falls Church, Va). It was a wonderful paper.
owever, I think we should be very careful in interpreting the
esults, and this is why. By matching the patients, I think you made
crucial mistake. We all know that one of the most important and
ignificant factors contributing to the failure of the maze procedure
s the duration of AF before surgery. I did not see any matching
etween these two very significant parameters; that is, the type of
F was never found as a significant factor in predicting AF done
n follow-up.
The other question that I have is more from a technical aspect.
ow can you perform the full maze procedure with a bipolar RF
blation technique? Can you elaborate more about this? And how
any times do you clamp and ablate with the RF technique?
Last, it is kind of surprising to find such a stark difference
etween the two RF devices. Can you share with us your thoughts
bout why it happens?
Dr Stulak. Dr Ad, I appreciate your questions. It is difficult at
imes to perform the full Cox maze operation. The lesion sets are
s close as they can be. The connecting lesion down to the mitral
nnulus from the encircling pulmonary vein lesion is the hardest
ne, and a lot of times the surgeons do what they can, but then use
ryolesions as part of this lesion.
Dr Ad. Did you use cryolesions or not?
Dr Stulak. We did, at the mitral annulus and then at the
ricuspid annulus, as described. We did our best to make the
onnecting lesion to the mitral annulus.
In terms of number of burns, with the AtriCure device, typi-
ally the surgeons at the Mayo Clinic apply two burns with each
esion set.
Dr Ad. What about the duration of AF before surgery? That isThe Journal of ThoracicDr Stulak. We did not identify that in our biatrial experience
o be a predictor of failure, only left atrial size and the presence of
oncomitant mitral valve surgery. In this study, patients in the CS
roup actually had a longer preoperative duration of their arrhyth-
ia, which was not significant. This clinical characteristic did not
eem to have any impact in this study, nor was that found to be
ignificant in our biatrial CS experience. This is an important point
hat I failed to include in my presentation.
Dr Shelly C. Lall (St Louis, Mo). I would like to applaud you,
r Stulak, and your colleagues for completing this study and
resenting your data today. I have one question for you. Did the
ame surgeon that performed the CS procedures also do the RF
blation procedures? If not, could that have influenced your
esults?
Dr Stulak. Dr Lall, I enjoyed your presentation yesterday very
uch and I thank you for your question. There were six different
urgeons performing the RF maze procedure, and these same six
urgeons also performed the CS maze operations. I grant you, the
atients in this series represent the first group of patients on whom
e have used this technology, so of course, the question of a
urgeon or even an institutional learning curve becomes relevant.
e examined our results in terms of the surgeons and examined
hether there were different freedom from AF rates for each, and
here was no difference.
Dr Weisel. But the same surgeon did both procedures? That
as her question.
Dr Stulak. All the surgeons at the Mayo Clinic have performed
oth operations.
Dr John Pepper (London, United Kingdom). Did you examine
trial transport or the pattern of ventricular filling and compare it
ith the two groups?
Dr Stulak. No, sir. That is very important. We did not. We
trictly looked at freedom from AF.
Dr Pepper. Getting a nice pretty electrocardiogram is one
hing, but altering atrial transport is another.
Dr Stulak. Point very well taken.
Dr John D. Puskas (Atlanta, Ga). Dr Stulak, the issues of
ransmurality are foremost in our minds. Your institution has
rovided some of the data demonstrating that transmurality can be
ery reliably achieved with bipolar RF. If we are achieving trans-
urality with bipolar RF, and we have to assume we are achieving
ransmurality with a CS technique, why is there a difference in
hese outcomes? Are we now to go back and doubt or question our
ransmurality data with either technique, or is it something differ-
nt about the healing mechanism after an RF injury versus a CS
njury, or is this simply some sort of an anomaly and we are not to
raw any conclusion about the efficacy of RF?
Dr Stulak. Outstanding question. I think that the key is trans-
urality. Studies have shown that conduction block during surgery
oes not necessarily equate with transmurality and also that trans-
urality histologically does not equate with clinical success. I
hink we do not have a complete understanding of what is at play.
ome studies have shown that transmurality cannot be achieved
ntil some weeks or months after the operation. I think there is ahe most important factor in predicting failure. lot about “transmurality” that we don’t understand.and Cardiovascular Surgery ● Volume 133, Number 4 1027
